Company
Check-Cap is a young and dynamic medical device company with a breakthrough solution for Colorectal Cancer Screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is expected to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy.
Founded in early 2005, Check-Cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. The system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis.
Check-Cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colonic screening procedures.
Colorectal cancer is the Western world's second largest cancer killer, despite being 90% preventable or curable with early screening. Since Check-Cap's technology is the first to offer accurate, non-invasive polyp detection with no cathartic preparation, it is uniquely positioned to significantly increase CRC screening compliance without compromising screening accuracy. Because Check-Cap is simple and 'self-administered', it will also free up resources and increase screening throughput, thus saving many lives. Check-Cap intends to establish the next gold standard in colon cancer screening, meeting the enormous medical need of an estimated 35 million patients annually in a fast-growing $25B market.
for more information about the market opportunity and clinical need
